Reply to: “Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed”
Hepatology International · 2024
DOI: 10.1007/s12072-024-10682-6 ↗Kurz gefasst
Leserbrief in der Zeitschrift Hepatology International, 2024. Verfasst von Zhen-Xin Zeng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Phenylurea Compounds, Quinolines. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China.
- Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Dongjie Road 134, Fuzhou, 350001, Fujian Province, China.
- Department of Interventional Radiology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, China.
- Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China. yanmaolin74@163.com.
- Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Dongjie Road 134, Fuzhou, 350001, Fujian Province, China. yanmaolin74@163.com.
Zitieren
APA
Zeng, Z. X., Wu, J. Y., Zhuang, S. W., & Yan, M. L. (2024). Reply to: “Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed”. Hepatology International. https://doi.org/10.1007/s12072-024-10682-6
Vancouver
Zeng ZX, Wu JY, Zhuang SW, Yan ML. Reply to: “Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed”. Hepatology International. 2024. doi:10.1007/s12072-024-10682-6
BibTeX
@article{Zeng2024,
author = {Zeng, Zhen-Xin and Wu, Jia-Yi and Zhuang, Shao-Wu and Yan, Mao-Lin},
title = {Reply to: “Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed”},
journal = {Hepatology International},
year = {2024},
doi = {10.1007/s12072-024-10682-6}
}
EUVIMED